Brief: Kobayashi Pharmaceutical- Chairman And President To Resign Over Beni-Koji Dietary Supplement Problem
July 23 (Reuters) - Kobayashi Pharmaceutical Co Ltd
4967.T :
* KOBAYASHI PHARMACEUTICAL: CHAIRMAN AND PRESIDENT TO RESIGN
OVER
BENI-KOJI DIETARY SUPPLEMENT PROBLEM
* KOBAYASHI PHARMACEUTICAL: SENIOR EXECUTIVE DIRECTOR
SATOSHI
YAMANE TO BECOME PRESIDENT, EFFECTIVE AUG 8
Source text for Eikon: ID:
Further company coverage: 4967.T
(Reporting by Tokyo Newsroom)
((+81345201189;))
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows